- Home
- TMQ vs PRME Comparison
TMQ vs PRME Comparison
Compare TMQ & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMQ
- PRME
- Stock Information
- Founded
- TMQ 2004
- PRME 2019
- Country
- TMQ Canada
- PRME United States
- Employees
- TMQ N/A
- PRME N/A
- Industry
- TMQ Precious Metals
- PRME Medicinal Chemicals and Botanical Products
- Sector
- TMQ Basic Materials
- PRME Health Care
- Exchange
- TMQ Nasdaq
- PRME Nasdaq
- Market Cap
- TMQ 226.7M
- PRME 191.7M
- IPO Year
- TMQ N/A
- PRME 2022
- Fundamental
- Price
- TMQ $1.89
- PRME $4.29
- Analyst Decision
- TMQ
- PRME Buy
- Analyst Count
- TMQ 0
- PRME 6
- Target Price
- TMQ N/A
- PRME $9.38
- AVG Volume (30 Days)
- TMQ 613.8K
- PRME 5.4M
- Earning Date
- TMQ 07-10-2025
- PRME 08-04-2025
- Dividend Yield
- TMQ N/A
- PRME N/A
- EPS Growth
- TMQ N/A
- PRME N/A
- EPS
- TMQ N/A
- PRME N/A
- Revenue
- TMQ N/A
- PRME $3,846,000.00
- Revenue This Year
- TMQ N/A
- PRME $104.12
- Revenue Next Year
- TMQ N/A
- PRME $108.24
- P/E Ratio
- TMQ N/A
- PRME N/A
- Revenue Growth
- TMQ N/A
- PRME 550.76
- 52 Week Low
- TMQ $0.47
- PRME $1.11
- 52 Week High
- TMQ $2.09
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- TMQ 71.19
- PRME 69.86
- Support Level
- TMQ $1.30
- PRME $4.01
- Resistance Level
- TMQ $2.02
- PRME $4.83
- Average True Range (ATR)
- TMQ 0.12
- PRME 0.52
- MACD
- TMQ 0.05
- PRME 0.15
- Stochastic Oscillator
- TMQ 65.97
- PRME 74.82
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.